Evoq Therapeutics
Ann Arbor
About Evoq Therapeutics
Evoq Therapeutics is a cancer immunotherapy company that provides disease-specific immune modulators to treat patients afflicted with autoimmune diseases. Its technology platform utilizes a proprietary NanoDisc that has been optimized to deliver antigens to restore immune tolerance.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $2.0M
- Last round: Grant (Aug 2024)
- Website: evoqtherapeutics.com
- Phone: [email protected]
Industries & Categories
Biopharma, Biotechnology, Health Care, Life Science, Medical
Social Profiles
Canonical: https://fsome.com/organization/evoq-therapeutics-97539 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.